JP2015512399A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015512399A5 JP2015512399A5 JP2015503294A JP2015503294A JP2015512399A5 JP 2015512399 A5 JP2015512399 A5 JP 2015512399A5 JP 2015503294 A JP2015503294 A JP 2015503294A JP 2015503294 A JP2015503294 A JP 2015503294A JP 2015512399 A5 JP2015512399 A5 JP 2015512399A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- group
- alkyl
- hydrogen
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 19
- 125000000217 alkyl group Chemical group 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 16
- 239000001257 hydrogen Substances 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 6
- -1 methoxyethyl Chemical group 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 3
- MKYRMMMSZSVIGD-UHFFFAOYSA-N thieno[3,2-c]pyridine Chemical compound N1=CC=C2SC=CC2=C1 MKYRMMMSZSVIGD-UHFFFAOYSA-N 0.000 claims 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- 125000006371 dihalo methyl group Chemical group 0.000 claims 2
- 125000006232 ethoxy propyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 125000004970 halomethyl group Chemical group 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- 229930192474 thiophene Natural products 0.000 claims 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000004953 trihalomethyl group Chemical group 0.000 claims 2
- 125000006657 (C1-C10) hydrocarbyl group Chemical group 0.000 claims 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- 208000005440 Basal Cell Neoplasms Diseases 0.000 claims 1
- 206010004146 Basal cell carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000000172 Medulloblastoma Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 201000008968 osteosarcoma Diseases 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261614954P | 2012-03-23 | 2012-03-23 | |
| US61/614,954 | 2012-03-23 | ||
| PCT/US2013/031311 WO2013142253A2 (en) | 2012-03-23 | 2013-03-14 | TREATMENT OF PANCREATIC AND RELATED CANCERS WITH 5-ACYL-6,7-DIHYDROTHIENO[3,2-c]PYRIDINES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015512399A JP2015512399A (ja) | 2015-04-27 |
| JP2015512399A5 true JP2015512399A5 (https=) | 2016-06-23 |
| JP6117334B2 JP6117334B2 (ja) | 2017-04-19 |
Family
ID=49223442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015503294A Active JP6117334B2 (ja) | 2012-03-23 | 2013-03-14 | 膵臓癌および関連するがんの５−アシル−６，７−ジヒドロチエノ［３，２−ｃ］ピリジンでの処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9242994B2 (https=) |
| EP (1) | EP2828267B1 (https=) |
| JP (1) | JP6117334B2 (https=) |
| CN (1) | CN104364257B (https=) |
| AU (1) | AU2013235487B2 (https=) |
| CA (1) | CA2868356C (https=) |
| WO (1) | WO2013142253A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6117334B2 (ja) * | 2012-03-23 | 2017-04-19 | メモリアル スローン−ケタリング キャンサー センター | 膵臓癌および関連するがんの５−アシル−６，７−ジヒドロチエノ［３，２−ｃ］ピリジンでの処置 |
| WO2017218874A1 (en) * | 2016-06-16 | 2017-12-21 | Memorial Sloan-Kettering Cancer Center | Hedgehog acyltransferase inhibitors and uses thereof |
| WO2021212010A2 (en) * | 2020-04-17 | 2021-10-21 | The Trustees Of Indiana University | Small molecule antiviral drug treatment for human papillomavirus infections |
| EP4727553A2 (en) | 2023-06-13 | 2026-04-22 | The Trustees of Indiana University | Small molecule antiviral drug treatment for human papillomavirus infections |
| WO2025153715A1 (en) * | 2024-01-19 | 2025-07-24 | Scenic Biotech Bv | Heterocyclic pla2g15 inhibitors and their use in therapy, in the treatment of diseases characterized by lysosomal dysregulation |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2315274A1 (fr) | 1975-06-27 | 1977-01-21 | Parcor | Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications |
| US4749692A (en) | 1977-06-22 | 1988-06-07 | Sanofi, S.A. | Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity |
| JP2001514631A (ja) * | 1997-03-07 | 2001-09-11 | ノボ ノルディスク アクティーゼルスカブ | ４，５，６，７−テトラヒドロ−チエノ［３，２−ｃ］ピリジン誘導体類、それらの製造方法及び使用 |
| DE102005009440A1 (de) | 2005-03-02 | 2006-09-07 | Merck Patent Gmbh | Thienopyridinderivate |
| US8263607B2 (en) * | 2007-05-22 | 2012-09-11 | Astellas Pharma Inc. | 1-substituted tetrahydroisoquinoline compound |
| WO2009073203A1 (en) | 2007-12-04 | 2009-06-11 | Amgen Inc. | Trp-m8 receptor ligands and their use in treatments |
| AR070317A1 (es) * | 2008-02-06 | 2010-03-31 | Osi Pharm Inc | Furo (3,2-c) piridina y tieno (3,2-c) piridinas |
| TW200944530A (en) | 2008-04-09 | 2009-11-01 | Gruenenthal Chemie | Substituted sulfonamide derivatives |
| HRP20120822T1 (hr) * | 2008-10-24 | 2012-11-30 | Grünenthal GmbH | Supstituirani 4,5,6,7-tetrahidrotienopiridini kao kcnq2/3 modulatori za lijeäśenje boli, epilepsije i urinarne inkontinencije |
| WO2010101230A1 (ja) | 2009-03-05 | 2010-09-10 | アステラス製薬株式会社 | キノキサリン化合物 |
| EP2286808A1 (en) | 2009-08-18 | 2011-02-23 | Rheinische Friedrich-Wilhelms Universität | Cytohesin inhibitors |
| DE102010013716A1 (de) | 2010-03-31 | 2011-10-06 | Rheinische Friedrich-Wilhelms-Universität Bonn Körperschaft des öffentlichen Rechts | Verwendung von Cytohesin-Inhibitoren |
| JP6117334B2 (ja) * | 2012-03-23 | 2017-04-19 | メモリアル スローン−ケタリング キャンサー センター | 膵臓癌および関連するがんの５−アシル−６，７−ジヒドロチエノ［３，２−ｃ］ピリジンでの処置 |
-
2013
- 2013-03-14 JP JP2015503294A patent/JP6117334B2/ja active Active
- 2013-03-14 CN CN201380025406.9A patent/CN104364257B/zh not_active Expired - Fee Related
- 2013-03-14 EP EP13764896.0A patent/EP2828267B1/en active Active
- 2013-03-14 US US14/387,033 patent/US9242994B2/en not_active Expired - Fee Related
- 2013-03-14 CA CA2868356A patent/CA2868356C/en not_active Expired - Fee Related
- 2013-03-14 AU AU2013235487A patent/AU2013235487B2/en not_active Ceased
- 2013-03-14 WO PCT/US2013/031311 patent/WO2013142253A2/en not_active Ceased
-
2016
- 2016-01-22 US US15/004,847 patent/US9597320B2/en not_active Expired - Fee Related
-
2017
- 2017-03-15 US US15/459,911 patent/US9943507B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015512399A5 (https=) | ||
| JP2010504286A5 (https=) | ||
| JP2009263394A5 (https=) | ||
| CN109661394A (zh) | Fgfr4抑制剂、其制备方法与药学上的应用 | |
| JP2013520443A5 (https=) | ||
| JP2013507425A5 (https=) | ||
| JP2013537203A5 (https=) | ||
| JP2015531747A5 (https=) | ||
| JP2010523670A5 (https=) | ||
| JP2010502730A5 (https=) | ||
| JP2011509949A5 (https=) | ||
| JP2013510124A5 (https=) | ||
| JP2011527666A5 (https=) | ||
| JP2012092103A5 (https=) | ||
| AR064452A1 (es) | Derivados de 1,2,4 oxadiazol-indol,composiciones farmaceuticas que los comprenden y usos en trastornos asociados a receptores s1p1. | |
| JP2014508811A5 (https=) | ||
| JP2012136540A5 (https=) | ||
| JP2013516393A5 (https=) | ||
| JP2015501782A5 (https=) | ||
| JP2013543842A5 (https=) | ||
| JP2016501185A5 (https=) | ||
| JP2013540712A5 (https=) | ||
| RU2016130932A (ru) | Производные хинолона как ингибиторы рецептора фактора роста фибробластов | |
| JP2017509689A5 (https=) | ||
| JP2013510178A5 (https=) |